Aggressive natural killer-like T-cell malignancy with leukemic presentation following solid organ transplantation

American Journal of Clinical Pathology

Volumn 111, Issue 5, 1999, Pages 663-671

  Natkunam, Yasodha ^a   Warnke, Roger A ^a   Zehnder, James L ^a   Combleet, P Joanne ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Immunosuppression; Large granular lymphocytes; NK cells; NK like T cell leukemia; NK like T cell lymphoma; Posttransplant lymphoproliferative disorder

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; MONOCLONAL ANTIBODY; PREDNISONE; T LYMPHOCYTE RECEPTOR; VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; NATURAL KILLER CELL; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; T CELL LEUKEMIA; VIRUS DETECTION;

EID: 0032924605     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.5.663     Document Type: Article

References (30)

1. Hanto DW, Frizzera G, Purtilo DT, et al. Clinical spectrum of lymphoproliferative disorders in renal transplant recipients and evidence for the role of Epstein-Barr virus. Cancer Res. 1981;41:4253-4261.
2. Hanto DW, Gajl-Peczalska KJ, Frizzzera G, et al. Epstein-Barr virus induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation: clinical, pathologic, and virologic findings and implications for therapy. Ann Surg. 1983;198:356-369.
3. Frizzera G, Hanto DW, Gajl-Peczalska KJ, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res. 1981;41:4262-4279.
4. Craig FE, Gulley ML, Banks PM. Posttransplantation lymphoproliferative disorders. Am J Clin Pathol. 1993;99:265-276.
5. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphology and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552-565.
6. Van Gorp J, Doornewaard H, Verdonck LF, et al. Posttransplant T-cell lymphoma: report of three cases and a review of the literature. Cancer. 1994;73:3064-3072.
7. Shiong YS, Lian JD, Lin CY, et al. Epstein-Barr virus-associated T-cell lymphoma of the maxillary sinus in a renal transplant recipient. Transplant Proc. 1992;24:1929-1931.
8. Kumar S, Kumar D, Kingma DW, et al. Epstein-Barr virus associated T-cell lymphoma in a renal transplant patient. Am J Surg Pathol. 1993;17:1046-1053.
9. Waller EK, Ziemianska M, Bangs CD, et al. Characterization of posttransplant lymphomas that express T-cell-associated markers: immunophenotypes, molecular genetics, cytogenetics, and heterotransplantation in severe combined immunodeficient mice. Blood. 1993;82:247-261.
10. Macon WR, Williams ME, Greer JP, et al. Natural killer-like T cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood. 1996; 87:1474-1483.
11. Bindl JM, Warnke RA. Advantages of detecting monoclonal antibody binding to tissue sections with biotin and avidin reagents in Coplin jars. Am J Clin Pathol. 1986;85:490-493.
12. Van de Rijn M, Cleary ML, Variakojis D, et al. Epstein-Barr virus clonality in lymphomas in patients with rheumatoid arthritis. Arthritis Rheum. 1996;39:638-642.
13. Barch MJ, ed. ACT Cytogenetics Laboratory Manual. 2nd ed. New York, NY Raven Press; 1991:222.
14. Cleary ML, Chao J, Warnke R, et al. Immunoglobulin gene rearrangement as a diagnostic criterion of B cell lymphoma. Proc Natl Acad Sci USA. 1984;81:593-597.
15. Cleary ML, Nalesnik MA, Shearer WT, et al. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood. 1988;72:349-352.
16. Bottaro M, Berti E, Biondi A, et al. Heteroduplex analysis for T-cell receptor γ gene rearrangement for diagnosis and monitoring of cutaneous T-cell lymphomas. Blood. 1994;83:3271-3278.
17. Zutter MM, Martin PJ, Sale GE, et al. Epstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood. 1988;72:520-529.
18. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus-associated lymphoproliferation after bone marrow transplantation. Blood. 1988;71:1234-1243.
19. Hanto DW, Frizzera G, Gajl-Peczalska KJ, et al. Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation. 1985;39:461-472.
20. Kowal-Vern A, Swinnen L, Pyle J, et al. Characterization of postcardiac transplant lymphomas: histology, immunophenotyping, immunohistochemistry, and gene rearrangement. Arch Pathol Lab Med. 1996;120:41-48.
21. Scott AA, Head DR, Kopecky KJ, et al. HLA-DR-, CD33+, CD56+, CD16-myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994;84:244-255.
22. Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity. Blood. 1997;90:2417-2428.
23. Sun T, Schulman P, Kolitz J, et al. A study of lymphoma of large granular lymphocytes with modern modalities: report of two cases and review of the literature. Am J Hematol. 1992;40:135-145.
24. Emile JF, Boulland ML, Haioun C, et al. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood. 1996;87:1466-1473.
25. Picker LJ, Brenner MB, Michie S, et al. Expression of T cell receptor delta chains in benign and malignant T lineage lymphoproliferations. Am J Pathol. 1988;132:401-405.
26. Jaffe ES, Chan JKC, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/NK lymphomas: definitions, differential diagnosis, and epidemiology. Am J Surg Pathol. 1996;20:103-111.
27. Gentile TC, Uner AH, Hutchison RE, et al. CD3+ CD56+ aggressive variant of large granular lymphocyte leukemia. Blood. 1994;84:2315-2321.
28. Feher O, Barilla D, Locker J, et al. T-cell large granular lymphocytic leukemia following orthotopic liver transplantation. Am J Hematol. 1995;49:216-220.
29. Jaffe ES. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood. 1996;87:1207-1210.
30. Erickson J, Finger L, Sun L, et al. Deregulation of c-myc by translocation of the alpha-locus of the T-cell receptor in T-cell leukemias. Science. 1986;232:884-886.